Does METOPROLOL Cause Injection site mass? 136 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Injection site mass have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.3% of all adverse event reports for METOPROLOL.
136
Reports of Injection site mass with METOPROLOL
0.3%
of all METOPROLOL reports
16
Deaths
42
Hospitalizations
How Dangerous Is Injection site mass From METOPROLOL?
Of the 136 reports, 16 (11.8%) resulted in death, 42 (30.9%) required hospitalization, and 5 (3.7%) were considered life-threatening.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which METOPROLOL Alternatives Have Lower Injection site mass Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE